Easy Access and Express Report Delivery Service
The pharmaceutical industry, it is composed of companies developing and manufacturing innovative medicines and generic pharmaceuticals, as well as over–the-counter drug products. The sector is made up of a number of sub-sectors that service different market segments. Health products are vitamins, minerals, herbal medicines, homeopathic preparations, probiotics and even some traditional medicines are also prescribed by doctor or any equivalent physician. In this report, we mainly study the pharma and healthcare product. Highlights The global Pharma and Health Care market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029. North America is the largest consumption place, with a consumption market share nearly 50%. Following North America, Asia-Pacific is the second largest consumption place with the consumption market share of 25%. Market competition is intense. The key players are Johnson & Johnson, Novartis, Roche, AbbVie, Merck & Co., etc. The top five vendors held 20% of the market share. Report Scope This report aims to provide a comprehensive presentation of the global market for Pharma and Health Care, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharma and Health Care. The Pharma and Health Care market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Pharma and Health Care market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments. The report will help the Pharma and Health Care companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions. Key Companies & Market Share Insights In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
1 Preface 1.1 Scope of Report 1.2 Reasons for Doing This Study 1.3 Research Methodology 1.4 Research Process 1.5 Data Source 1.5.1 Secondary Sources 1.5.2 Primary Sources 2 Market Overview 2.1 Product Definition 2.2 Pharma and Health Care by Format 2.2.1 Market Value Comparison by Format (2018 VS 2022 VS 2029) 1.2.2 Bottle 1.2.3 Blister 1.2.4 Others 2.3 Pharma and Health Care by Prescription 2.3.1 Market Value Comparison by Prescription (2018 VS 2022 VS 2029) 2.3.2 OTC Drugs 2.3.3 Prescription Drugs 2.4 Assumptions and Limitations 3 Pharma and Health Care Breakdown Data by Format 3.1 Global Pharma and Health Care Historic Market Size by Format (2018-2023) 3.2 Global Pharma and Health Care Forecasted Market Size by Format (2023-2028) 4 Pharma and Health Care Breakdown Data by Prescription 4.1 Global Pharma and Health Care Historic Market Size by Prescription (2018-2023) 4.2 Global Pharma and Health Care Forecasted Market Size by Prescription (2018-2023) 5 Global Growth Trends 5.1 Global Pharma and Health Care Market Perspective (2018-2029) 5.2 Global Pharma and Health Care Growth Trends by Region 5.2.1 Global Pharma and Health Care Market Size by Region: 2018 VS 2022 VS 2029 5.2.2 Pharma and Health Care Historic Market Size by Region (2018-2023) 5.2.3 Pharma and Health Care Forecasted Market Size by Region (2024-2029) 5.3 Pharma and Health Care Market Dynamics 5.3.1 Pharma and Health Care Industry Trends 5.3.2 Pharma and Health Care Market Drivers 5.3.3 Pharma and Health Care Market Challenges 5.3.4 Pharma and Health Care Market Restraints 6 Market Competitive Landscape by Players 6.1 Global Top Pharma and Health Care Players by Revenue 6.1.1 Global Top Pharma and Health Care Players by Revenue (2018-2023) 6.1.2 Global Pharma and Health Care Revenue Market Share by Players (2018-2023) 6.2 Global Pharma and Health Care Industry Players Ranking, 2021 VS 2022 VS 2023 6.3 Global Key Players of Pharma and Health Care Head office and Area Served 6.4 Global Pharma and Health Care Players, Product Type & Application 6.5 Global Pharma and Health Care Players, Date of Enter into This Industry 6.6 Global Pharma and Health Care Market CR5 and HHI 6.7 Global Players Mergers & Acquisition 7 North America 7.1 North America Pharma and Health Care Market Size (2018-2029) 7.2 North America Pharma and Health Care Market Growth Rate by Country: 2018 VS 2022 VS 2029 7.3 North America Pharma and Health Care Market Size by Country (2018-2023) 7.4 North America Pharma and Health Care Market Size by Country (2024-2029) 7.5 United States 7.6 Canada 8 Europe 8.1 Europe Pharma and Health Care Market Size (2018-2029) 8.2 Europe Pharma and Health Care Market Growth Rate by Country: 2018 VS 2022 VS 2029 8.3 Europe Pharma and Health Care Market Size by Country (2018-2023) 8.4 Europe Pharma and Health Care Market Size by Country (2024-2029) 7.4 Germany 7.5 France 7.6 U.K. 7.7 Italy 7.8 Russia 7.9 Nordic Countries 9 Asia-Pacific 9.1 Asia-Pacific Pharma and Health Care Market Size (2018-2029) 9.2 Asia-Pacific Pharma and Health Care Market Growth Rate by Country: 2018 VS 2022 VS 2029 9.3 Asia-Pacific Pharma and Health Care Market Size by Country (2018-2023) 9.4 Asia-Pacific Pharma and Health Care Market Size by Country (2024-2029) 8.4 China 8.5 Japan 8.6 South Korea 8.7 Southeast Asia 8.8 India 8.9 Australia 10 Latin America 10.1 Latin America Pharma and Health Care Market Size (2018-2029) 10.2 Latin America Pharma and Health Care Market Growth Rate by Country: 2018 VS 2022 VS 2029 10.3 Latin America Pharma and Health Care Market Size by Country (2018-2023) 10.4 Latin America Pharma and Health Care Market Size by Country (2024-2029) 9.4 Mexico 9.5 Brazil 11 Middle East & Africa 11.1 Middle East & Africa Pharma and Health Care Market Size (2018-2029) 11.2 Middle East & Africa Pharma and Health Care Market Growth Rate by Country: 2018 VS 2022 VS 2029 11.3 Middle East & Africa Pharma and Health Care Market Size by Country (2018-2023) 11.4 Middle East & Africa Pharma and Health Care Market Size by Country (2024-2029) 10.4 Turkey 10.5 Saudi Arabia 10.6 UAE 12 Players Profiled 11.1 Johnson & Johnson 11.1.1 Johnson & Johnson Company Detail 11.1.2 Johnson & Johnson Business Overview 11.1.3 Johnson & Johnson Pharma and Health Care Introduction 11.1.4 Johnson & Johnson Revenue in Pharma and Health Care Business (2017-2022) 11.1.5 Johnson & Johnson Recent Development 11.2 Novartis 11.2.1 Novartis Company Detail 11.2.2 Novartis Business Overview 11.2.3 Novartis Pharma and Health Care Introduction 11.2.4 Novartis Revenue in Pharma and Health Care Business (2017-2022) 11.2.5 Novartis Recent Development 11.3 Roche 11.3.1 Roche Company Detail 11.3.2 Roche Business Overview 11.3.3 Roche Pharma and Health Care Introduction 11.3.4 Roche Revenue in Pharma and Health Care Business (2017-2022) 11.3.5 Roche Recent Development 11.4 AbbVie 11.4.1 AbbVie Company Detail 11.4.2 AbbVie Business Overview 11.4.3 AbbVie Pharma and Health Care Introduction 11.4.4 AbbVie Revenue in Pharma and Health Care Business (2017-2022) 11.4.5 AbbVie Recent Development 11.5 Merck & Co. 11.5.1 Merck & Co. Company Detail 11.5.2 Merck & Co. Business Overview 11.5.3 Merck & Co. Pharma and Health Care Introduction 11.5.4 Merck & Co. Revenue in Pharma and Health Care Business (2017-2022) 11.5.5 Merck & Co. Recent Development 11.6 Bristol Myers Squibb 11.6.1 Bristol Myers Squibb Company Detail 11.6.2 Bristol Myers Squibb Business Overview 11.6.3 Bristol Myers Squibb Pharma and Health Care Introduction 11.6.4 Bristol Myers Squibb Revenue in Pharma and Health Care Business (2017-2022) 11.6.5 Bristol Myers Squibb Recent Development 11.7 GlaxoSmithKline 11.7.1 GlaxoSmithKline Company Detail 11.7.2 GlaxoSmithKline Business Overview 11.7.3 GlaxoSmithKline Pharma and Health Care Introduction 11.7.4 GlaxoSmithKline Revenue in Pharma and Health Care Business (2017-2022) 11.7.5 GlaxoSmithKline Recent Development 11.8 Pfizer 11.8.1 Pfizer Company Detail 11.8.2 Pfizer Business Overview 11.8.3 Pfizer Pharma and Health Care Introduction 11.8.4 Pfizer Revenue in Pharma and Health Care Business (2017-2022) 11.8.5 Pfizer Recent Development 11.9 Sanofi 11.9.1 Sanofi Company Detail 11.9.2 Sanofi Business Overview 11.9.3 Sanofi Pharma and Health Care Introduction 11.9.4 Sanofi Revenue in Pharma and Health Care Business (2017-2022) 11.9.5 Sanofi Recent Development 11.10 Takeda 11.10.1 Takeda Company Detail 11.10.2 Takeda Business Overview 11.10.3 Takeda Pharma and Health Care Introduction 11.10.4 Takeda Revenue in Pharma and Health Care Business (2017-2022) 11.10.5 Takeda Recent Development 11.11 AstraZeneca 11.11.1 AstraZeneca Company Detail 11.11.2 AstraZeneca Business Overview 11.11.3 AstraZeneca Pharma and Health Care Introduction 11.11.4 AstraZeneca Revenue in Pharma and Health Care Business (2017-2022) 11.11.5 AstraZeneca Recent Development 11.12 Bayer 11.12.1 Bayer Company Detail 11.12.2 Bayer Business Overview 11.12.3 Bayer Pharma and Health Care Introduction 11.12.4 Bayer Revenue in Pharma and Health Care Business (2017-2022) 11.12.5 Bayer Recent Development 11.13 Eli Lilly & Co. 11.13.1 Eli Lilly & Co. Company Detail 11.13.2 Eli Lilly & Co. Business Overview 11.13.3 Eli Lilly & Co. Pharma and Health Care Introduction 11.13.4 Eli Lilly & Co. Revenue in Pharma and Health Care Business (2017-2022) 11.13.5 Eli Lilly & Co. Recent Development 11.14 Gilead Sciences 11.14.1 Gilead Sciences Company Detail 11.14.2 Gilead Sciences Business Overview 11.14.3 Gilead Sciences Pharma and Health Care Introduction 11.14.4 Gilead Sciences Revenue in Pharma and Health Care Business (2017-2022) 11.14.5 Gilead Sciences Recent Development 11.15 Amgen 11.15.1 Amgen Company Detail 11.15.2 Amgen Business Overview 11.15.3 Amgen Pharma and Health Care Introduction 11.15.4 Amgen Revenue in Pharma and Health Care Business (2017-2022) 11.15.5 Amgen Recent Development 11.16 Novo Nordisk 11.16.1 Novo Nordisk Company Detail 11.16.2 Novo Nordisk Business Overview 11.16.3 Novo Nordisk Pharma and Health Care Introduction 11.16.4 Novo Nordisk Revenue in Pharma and Health Care Business (2017-2022) 11.16.5 Novo Nordisk Recent Development 11.17 Teva 11.17.1 Teva Company Detail 11.17.2 Teva Business Overview 11.17.3 Teva Pharma and Health Care Introduction 11.17.4 Teva Revenue in Pharma and Health Care Business (2017-2022) 11.17.5 Teva Recent Development 11.18 Boehringer Ingelheim 11.18.1 Boehringer Ingelheim Company Detail 11.18.2 Boehringer Ingelheim Business Overview 11.18.3 Boehringer Ingelheim Pharma and Health Care Introduction 11.18.4 Boehringer Ingelheim Revenue in Pharma and Health Care Business (2017-2022) 11.18.5 Boehringer Ingelheim Recent Development 11.19 Biogen 11.19.1 Biogen Company Detail 11.19.2 Biogen Business Overview 11.19.3 Biogen Pharma and Health Care Introduction 11.19.4 Biogen Revenue in Pharma and Health Care Business (2017-2022) 11.19.5 Biogen Recent Development 11.20 Astellas 11.20.1 Astellas Company Detail 11.20.2 Astellas Business Overview 11.20.3 Astellas Pharma and Health Care Introduction 11.20.4 Astellas Revenue in Pharma and Health Care Business (2017-2022) 11.20.5 Astellas Recent Development 13 Report Conclusion 14 Disclaimer